Find Prulifloxacin manufacturers, exporters & distributors on PharmaCompass

Prulifloxacin

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 1 USDMF, 1 JDMF, 3 Listed Suppliers

4 API Suppliers
1 USDMF
1 JDMF
3 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 4 Europe, 1 Listed Dossiers

5 FDF Dossiers
4 Europe
1 Listed Dossiers

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Finished Drug Prices

globalSalesInformation
4 Finished Drug Prices

MARKET PLACE

4 APIs

marketPlace
4 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 123447-62-1, Pruvel, Nm441, Quisnon, Nm-441, Prulifloxacin [inn]

Molecular Formula

C₂₁H₂₀FN₃O₆S

Molecular Weight

461.5 g/mol

InChI Key

PWNMXPDKBYZCOO-UHFFFAOYSA-N

FDA UNII

J42298IESW

Prulifloxacin has been investigated for the treatment of Urinary Tract Infection.

1 2D Structure

Prulifloxacin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid

2.1.2 InChI

InChI=1S/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28)

2.1.3 InChI Key

PWNMXPDKBYZCOO-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C

2.2 Other Identifiers

2.2.1 UNII

J42298IESW

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 6-fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic Acid

2. Nm 441

3. Nm-441

4. Nm441

2.3.2 Depositor-Supplied Synonyms

1. 123447-62-1

2. Pruvel

3. Nm441

4. Quisnon

5. Nm-441

6. Prulifloxacin [inn]

7. Sword

8. Nm 441

9. Prulifloxacin (hydrochloride)

10. 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

11. J42298iesw

12. Nsc-759833

13. 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

14. Ncgc00164615-01

15. Prulifloxacin 100 Microg/ml In Acetonitrile

16. Dsstox_cid_26480

17. Dsstox_rid_81651

18. Dsstox_gsid_46480

19. 1h,4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic Acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo-

20. 1h,4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-

21. 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1h,4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

22. Ccris 7686

23. Cas-123447-62-1

24. Unii-j42298iesw

25. Pufloxacin Dioxolil

26. 6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

27. Prulifloxacin [mi]

28. Prulifloxacin [jan]

29. Mls006011767

30. Prulifloxacin [mart.]

31. Prulifloxacin [who-dd]

32. Chembl422648

33. Nad-441a

34. Opt-99

35. Schembl1650794

36. Dtxsid0046480

37. Chebi:32071

38. Bcp12727

39. Hy-b0024

40. Tox21_112235

41. Bbl034010

42. Mfcd00864847

43. S2071

44. Stk626148

45. Akos005559236

46. Nm441;af 3013

47. Prulifloxacin (nm441, Af 3013)

48. Tox21_112235_1

49. Ac-2012

50. Af 3012

51. Db11892

52. Nsc 759833

53. Sb18983

54. Ncgc00164615-02

55. Ncgc00164615-03

56. (+-)-7-(4-((z)-2,3-dihydroxy-2-butenyl)-1-piperazinyl)-6-fluoro-1-methyl-4-oxo-1h,4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic Acid, Cyclic Carbonate

57. As-13607

58. Smr000046722

59. Ft-0651733

60. P2058

61. F20576

62. 447p621

63. Prulifloxacin, >=98% (perchloric Acid Titration)

64. Sr-01000872596

65. Prulifloxacin, Antibiotic For Culture Media Use Only

66. Q-101929

67. Q3924793

68. Sr-01000872596-1

69. Brd-a92341659-001-01-6

70. 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-4-ium-1-yl]-4-oxo-1h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₀FN₃O₆S
Molecular Weight	461.5 g/mol
XLogP3	1
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	11
Rotatable Bond Count	4
Exact Mass	461.10568470 g/mol
Monoisotopic Mass	461.10568470 g/mol
Topological Polar Surface Area	125 Å²
Heavy Atom Count	32
Formal Charge	0
Complexity	931
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

Topoisomerase II Inhibitors

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)

4.2 ATC Code

J - Antiinfectives for systemic use

J01 - Antibacterials for systemic use

J01M - Quinolone antibacterials

J01MA - Fluoroquinolones

J01MA17 - Prulifloxacin

API SUPPLIERS